Turning point in drug prices is around the corner, says Cantor Fitzgerald’s Louise Chen

Louise Chen, Cantor Fitzgerald senior analyst, joins ‘Squawk Box’ to discuss Novo Nordisk’s CEO on Capitol Hill, when drug prices could start to come down, and more.